Observational study comparing long-term safety and efficacy of Deferasirox with Desferrioxamine therapy in chelation naive children with transfusional iron overload

European Journal of Haematology, 03/26/2012

Deferasirox (DFX) is well tolerable and at least as effective as Desferrioxamine (DFO) to maintain safe serum ferritin levels and normal growth progression in chelation–naive children.

Print Article Summary Cat 2 CME Report